Langabeer, S.E., et al. “Suboptimal Molecular Response to Tyrosine Kinase Inhibition Associated With Acquisition of a T240A ABL1 Kinase Domain Mutation in a Patient With Chronic Myeloid Leukemia”. Experimental Oncology, vol. 41, no. 1, June 2023, pp. 82-83, doi:10.32471/exp-oncology.2312-8852.vol-41-no-1.12685.